Lantheus Holdings Inc

$23.26 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Stock Analysis

last close $23.26
1-mo return -8.5%
3-mo return -9.4%
avg daily vol. 375.08T
52-week high 28.74
52-week low 10.52
market cap. $1.6B
forward pe 59.6
annual div. -
roe -5.4%
ltg forecast -
dividend yield -
annual rev. $376M
inst own. 94.2%
baraka

Subscribe now for daily local and international financial news

Subscribe